Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher A Shaw

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Neuromolecular Medicine|November 7, 2007
Neurodegenerative diseases: neurotoxins as sufficient etiologic agents?Christopher A Shaw, Günter U Höglinger
Toxics|October 26, 2022
Metals and Metalloids Increase in <i>Cycas micronesica</i> Seed Gametophyte Tissue in Shaded Growth ConditionsThomas E Marler, Christopher A Shaw
Communicative & Integrative Biology|February 8, 2014
Aluminum and the human diet revisitedChristopher A Shaw, Thomas E Marler
Neurology|February 6, 2009
The ALS/PDC syndrome of Guam and the cycad hypothesisReyniel Cruz-Aguado, Christopher A Shaw
Cellular and Molecular Biology (Noisy-Le-Grand, France)|May 7, 2002
Synergistic versus antagonistic actions of glutamate and glutathione: the role of excitotoxicity and oxidative stress in neuronal diseaseChristopher A Shaw, Jaswinder S Bains
Hortscience : a Publication of the American Society for Horticultural Science|February 23, 2010
Phenotypic Characteristics as Predictors of Phytosterols in Mature Cycas micronesica SeedsThomas E Marler, Christopher A Shaw
Journal of Inorganic Biochemistry|September 11, 2009
Aluminum hydroxide injections lead to motor deficits and motor neuron degenerationChristopher A Shaw, Michael S Petrik
Immunotherapy|November 28, 2014
Are there negative CNS impacts of aluminum adjuvants used in vaccines and immunotherapy?Christopher A Shaw, Dan Li, Lucija Tomljenovic
Neuroreport|July 28, 2009
The primary locus of motor neuron death in an ALS-PDC mouse modelGrace Lee, Tony Chu, Christopher A Shaw
Journal of Negative Results in Biomedicine|August 9, 2014
Reduction in hSOD1 copy number significantly impacts ALS phenotype presentation in G37R (line 29) mice: implications for the assessment of putative therapeutic agentsPierre Zwiegers, Grace Lee, Christopher A Shaw
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Neuromolecular Medicine|November 7, 2007
Neurodegenerative diseases: neurotoxins as sufficient etiologic agents?Christopher A Shaw, Günter U Höglinger
Toxics|October 26, 2022
Metals and Metalloids Increase in <i>Cycas micronesica</i> Seed Gametophyte Tissue in Shaded Growth ConditionsThomas E Marler, Christopher A Shaw
Communicative & Integrative Biology|February 8, 2014
Aluminum and the human diet revisitedChristopher A Shaw, Thomas E Marler
Neurology|February 6, 2009
The ALS/PDC syndrome of Guam and the cycad hypothesisReyniel Cruz-Aguado, Christopher A Shaw
Cellular and Molecular Biology (Noisy-Le-Grand, France)|May 7, 2002
Synergistic versus antagonistic actions of glutamate and glutathione: the role of excitotoxicity and oxidative stress in neuronal diseaseChristopher A Shaw, Jaswinder S Bains
Hortscience : a Publication of the American Society for Horticultural Science|February 23, 2010
Phenotypic Characteristics as Predictors of Phytosterols in Mature Cycas micronesica SeedsThomas E Marler, Christopher A Shaw
Journal of Inorganic Biochemistry|September 11, 2009
Aluminum hydroxide injections lead to motor deficits and motor neuron degenerationChristopher A Shaw, Michael S Petrik
Immunotherapy|November 28, 2014
Are there negative CNS impacts of aluminum adjuvants used in vaccines and immunotherapy?Christopher A Shaw, Dan Li, Lucija Tomljenovic
Neuroreport|July 28, 2009
The primary locus of motor neuron death in an ALS-PDC mouse modelGrace Lee, Tony Chu, Christopher A Shaw
Journal of Negative Results in Biomedicine|August 9, 2014
Reduction in hSOD1 copy number significantly impacts ALS phenotype presentation in G37R (line 29) mice: implications for the assessment of putative therapeutic agentsPierre Zwiegers, Grace Lee, Christopher A Shaw
Pageof 6